UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018834
Receipt number R000021786
Scientific Title Efficacy and Safety of endoscopic ultrasound-guided ethanol ablation therapy for pancreatic neuroendocrine tumors: A Pilot Study
Date of disclosure of the study information 2015/10/31
Last modified on 2019/03/14 16:35:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and Safety of endoscopic ultrasound-guided ethanol ablation therapy for pancreatic neuroendocrine tumors: A Pilot Study

Acronym

Ethanol ablation therapy for pancreatic neuroendocrine tumors

Scientific Title

Efficacy and Safety of endoscopic ultrasound-guided ethanol ablation therapy for pancreatic neuroendocrine tumors: A Pilot Study

Scientific Title:Acronym

Ethanol ablation therapy for pancreatic neuroendocrine tumors

Region

Japan


Condition

Condition

Pancreatic neuroendocrine tumor

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of EUS-guided ethanol ablation therapy for pancreatic neuroendocrine tumors

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Complete ablation rate
(Treatment responses were assessed according to enhanced residual tumor areas on CE-CT)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Ethanol injection into the tumor by using EUS

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)The diagnosis of p-NET(G1 or G2) was confirmed by pathology from a core biopsy specimen obtained by EUS-FNA(WHO 2010 classification)
2)Low suitability for surgery(ASA grade>=3) or refusal of surgery
3)The p-NET within 2 cm in diameter by using CE-CT
4)The p-NET with non-function or insulinoma

Key exclusion criteria

1)Severe allergy history against medical drug
2)Allergy for contrast medium
3)Allergy for ethanol
4)Cases that could not visualize or puncture by using EUS
5)Cases that were diagnosed NEC from a core biopsy specimen obtained by EUS-FNA(WHO2010 classification)
6)Located near the main pancreatic duct
7)PT<=50% or INR>=1.5
8)PLT<=50,000/uL
9)eGFR<=30 mL/min
10)Patients who administered more than 2 anti-thrombotic agent
11)Patients with performance status 2-4.
12)Patients with poor prognosis (less than 3-year)
13)Age<20
14)Patients without informed consent
15)Patients who are judged inappropriate by chief medical examiner

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hironari Kato

Organization

Okayama University Hospital

Division name

Department of Gastroenterology & Hepatology

Zip code


Address

2-5-1 Shikata-cho,Kita-ku Okayama-city Okayama

TEL

086-235-7219

Email

drkatocha@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuyuki Matsumoto

Organization

Okayama University Hospital

Division name

Department of Gastroenterology & Hepatology

Zip code


Address

2-5-1 Shikata-cho,Kita-ku Okayama-city Okayama

TEL

086-235-7219

Homepage URL


Email

matsumotokazuyuki0227@yahoo.co.jp


Sponsor or person

Institute

Okayama University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 31 Day


Related information

URL releasing protocol

www.lib.okayama-u.ac.jp/www/acta/pdf/70_4_313.pdf

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

5

Results

A total of five patients were treated. The median size of the tumor was 10 mm (range 7-14). Of the five patients, three underwent an additional session. The median volume of ethanol injection per session was 0.8 (range: 0.3-1.0) mL, and the total was 1.0 (0.9-1.8) mL. Complete ablation at 1 month was achieved in 4 of the 5 tumors (80%). During one year of follow-up, none of the patients reported any procedure-related adverse events, and no malignancy or lymph node metastasis was noted.

Results date posted

2019 Year 03 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

No adverse event

Outcome measures

Complete ablation at 1 month was achieved in 4 of the 5 tumors (80%).

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 27 Day

Date of IRB

2015 Year 10 Month 20 Day

Anticipated trial start date

2015 Year 10 Month 31 Day

Last follow-up date

2019 Year 03 Month 14 Day

Date of closure to data entry

2019 Year 03 Month 14 Day

Date trial data considered complete

2019 Year 03 Month 14 Day

Date analysis concluded

2019 Year 03 Month 15 Day


Other

Other related information



Management information

Registered date

2015 Year 08 Month 27 Day

Last modified on

2019 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021786


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name